Iman Osman
Impact in
- Oncology top 0.5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.5%
- MicroRNA in disease regulation
Papers in
- Oncology 93
- Cutaneous Melanoma Detection and Management 59
- Cancer Immunotherapy and Biomarkers 28
-
- MicroRNA in disease regulation 19
- Co-authors
- David Polsky (52 shared papers)Anna C. Pavlick (61 shared papers)Eva Hernando (36 shared papers)Farbod Darvishian (47 shared papers)Richard L. Shapiro (57 shared papers)Russell S. Berman (54 shared papers)Howard I. Scher (15 shared papers)Carlos Cordon‐Cardo (16 shared papers)
- Journals
- Journal of Translational Medicine (25 papers)Clinical Cancer Research (22 papers)Cancer (12 papers)Journal of Investigative Dermatology (9 papers)JNCI Journal of the National Cancer Institute (7 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Iman Osman
234 papers receiving 15.1k citations
Iman Osman's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 3.6k
- Cancer Research 1.6k
- Molecular Biology 3.5k
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 529
Countries citing papers authored by Iman Osman
This map shows the geographic impact of Iman Osman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Osman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Osman more than expected).
Fields of papers citing papers by Iman Osman
This network shows the impact of papers produced by Iman Osman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Osman. The network helps show where Iman Osman may publish in the future.
Co-authors
The 25 scholars most cited alongside Iman Osman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 242 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | BRAF mutation predicts sensitivity to MEK inhibition Hit paper breakdown → | 2005 | 1135 |
| 2 | 2009 | 484 | |
| 3 | 2004 | 481 | |
| 4 | The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Hit paper breakdown → | 2015 | 468 |
| 5 | 2014 | 346 | |
| 6 | Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment Hit paper breakdown → | 2022 | 334 |
| 7 | 2009 | 325 | |
| 8 | 2010 | 325 | |
| 9 | 2011 | 302 | |
| 10 | 2018 | 302 | |
| 11 | 2017 | 261 | |
| 12 | 2017 | 253 | |
| 13 | 2020 | 253 | |
| 14 | 2012 | 242 | |
| 15 | 1998 | 240 | |
| 16 | 2011 | 227 | |
| 17 | 2013 | 211 | |
| 18 | 2013 | 206 | |
| 19 | 2019 | 197 | |
| 20 | Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. | 2000 | 191 |
About Iman Osman
Iman Osman is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 242 papers that have together received 15.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (59 papers), Cancer Immunotherapy and Biomarkers (28 papers), Melanoma and MAPK Pathways (24 papers), MicroRNA in disease regulation (19 papers), Prostate Cancer Treatment and Research (16 papers), Bladder and Urothelial Cancer Treatments (5 papers), T-cell and B-cell Immunology (3 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.6k citations), Molecular Biology (3.5k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Immunology (529 citations). Iman Osman has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include David Polsky, Anna C. Pavlick, Eva Hernando, Farbod Darvishian, Richard L. Shapiro, Russell S. Berman, Howard I. Scher, Carlos Cordon‐Cardo, Nina Bhardwaj and Judy Zhong. Their work appears in journals such as Journal of Translational Medicine, Clinical Cancer Research, Cancer, Journal of Investigative Dermatology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.